Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cellid Faces Injunction Bid to Block Issuance of 4,796,163 Shares

Cellid Faces Injunction Bid to Block Issuance of 4,796,163 Shares

BitgetBitget2026/10/28 09:05
  • Cellid faces an injunction application filed Oct. 24, 2026, in Seoul Central District Court seeking to block a third-party share placement.
  • The proposed issuance comprises 4,796,163 registered common shares allocated to Huniverse Global at KRW 2,085 each.
  • Total proceeds would reach KRW 10 billion, with payment due Nov. 9, 2026.
  • The application also seeks to block four director appointments at the Nov. 10 extraordinary shareholder meeting, including related electronic vote counting.
  • The company received the application Oct. 28 and plans to appoint legal counsel to respond.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellid Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028000446), on October 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity

Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

智通财经•2026/11/12 01:01
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity